Australia markets closed

Nova Ltd. (NVMI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
216.87-2.24 (-1.02%)
As of 09:38AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 6.38B
Enterprise value 6.13B
Trailing P/E 49.33
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.03
Price/book (mrq)7.84
Enterprise value/revenue 11.28
Enterprise value/EBITDA 34.16

Trading information

Stock price history

Beta (5Y monthly) 1.40
52-week change 3102.90%
S&P500 52-week change 326.94%
52-week high 3219.74
52-week low 390.59
50-day moving average 3182.16
200-day moving average 3142.70

Share statistics

Avg vol (3-month) 3182.71k
Avg vol (10-day) 3163.26k
Shares outstanding 529.05M
Implied shares outstanding 629.05M
Float 828.95M
% held by insiders 10.01%
% held by institutions 178.74%
Shares short (15 May 2024) 41.14M
Short ratio (15 May 2024) 45.56
Short % of float (15 May 2024) 44.40%
Short % of shares outstanding (15 May 2024) 43.92%
Shares short (prior month 15 Apr 2024) 41.24M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 26.26%
Operating margin (ttm)26.25%

Management effectiveness

Return on assets (ttm)7.54%
Return on equity (ttm)19.50%

Income statement

Revenue (ttm)527.53M
Revenue per share (ttm)18.24
Quarterly revenue growth (yoy)7.30%
Gross profit (ttm)N/A
EBITDA 150.53M
Net income avi to common (ttm)138.54M
Diluted EPS (ttm)4.46
Quarterly earnings growth (yoy)6.40%

Balance sheet

Total cash (mrq)495.54M
Total cash per share (mrq)17.07
Total debt (mrq)242.89M
Total debt/equity (mrq)30.68%
Current ratio (mrq)2.26
Book value per share (mrq)27.27

Cash flow statement

Operating cash flow (ttm)159.9M
Levered free cash flow (ttm)99.67M